
12.59 Delayed Data As of 3:59pm ET | ![]() Today’s Change | 3.79 Today|||52-Week Range 13.00 | +46.74% Year-to-Date |
The 7 analysts offering 12-month price forecasts for Cogent Biosciences Inc have a median target of 17.00, with a high estimate of 23.00 and a low estimate of 15.00. The median estimate represents a +35.03% increase from the last price of 12.59.
The current consensus among 7 polled investment analysts is to Buy stock in Cogent Biosciences Inc. This rating has held steady since June, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.